Preliminary results from FLAGSHP-1: A phase 1 study of ERAS-601 as a monotherapy or in combination with cetuximab in patients (pts) previously treated for advanced chordoma.

被引：0
|
作者：
Gounder, Mrinal M.
Rosen, Ezra
Parikh, Aparna Raj
Conley, Anthony Paul
Hong, David S.
Sheth, Siddharth
Mai, Nicholas
Sgroe, Erica
Mitchell, Ryan
Picard, Roxana
Brail, Les H.
Cote, Gregory Michael
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol & Oncol, Dept Med, Boston, MA USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[4] Univ N Carolina, Chapel Hill, NC USA
[5] Erasca Inc, San Diego, CA USA
[6] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11522
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase 1b study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors
    Weekes, Colin
    Lockhart, A. Craig
    Lee, James J.
    Sturm, Isrid
    Cleton, Adriaan
    Huang, Funan
    Lenz, Heinz-Josef
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (09) : 2450 - 2458
  • [32] A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours
    Gazzah, Anas
    Boni, Valentina
    Soria, Jean-Charles
    Calles, Antonio
    Even, Caroline
    Doger, Bernard
    Mahjoubi, Linda
    Bahleda, Rastislav
    Ould-Kaci, Mahmoud
    Esler, Anne
    Nazabadioko, Serge
    Calvo, Emiliano
    EUROPEAN JOURNAL OF CANCER, 2018, 104 : 1 - 8
  • [33] Positive updated Results from Phase II Pemigatinib Study in Patients with previously treated advanced Bile Duct Cancer
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (11) : 618 - 618
  • [34] Updated Preliminary Results of a Phase 1b Dose Escalation and Dose Expansion Study of Tirabrutinib Alone or in Combination with Idelalisib or Entospletinib in Patients with Previously Treated Chronic Lymphocytic Leukemia
    Danilov, Alexey V.
    Herbaux, Charles
    Dyer, Martin J. S.
    Hillmen, Peter
    Rule, Simon
    Kio, Ebenezer A.
    Huang, Xi
    Mitra, Siddhartha
    Karlin, Lionel
    Fegan, Christopher
    BLOOD, 2018, 132
  • [35] PHASE II STUDY OF TWO ERIBULIN REGIMENS IN COMBINATION WITH ERLOTINIB IN PATIENTS (PTS) WITH PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Geater, S. L.
    Ianotti, N.
    Thongprasert, S.
    Spira, A.
    Smith, D.
    Lee, V.
    Lim, W-T.
    Gopalakrishna, P.
    Reynolds, C.
    Mok, T. S. K.
    ANNALS OF ONCOLOGY, 2012, 23 : 393 - 393
  • [36] Pembrolizumab for previously treated advanced cervical squamous cell cancer: Preliminary results from the phase 2 KEYNOTE-158 study
    Schellens, Jan H. M.
    Marabelle, Aurelien
    Zeigenfuss, Susan
    Ding, Jie
    Pruitt, Scott Knowles
    Chung, Hyun Cheol
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients
    Yoda, Satoshi
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Naoki, Katsuhiko
    Kawada, Ichiro
    Watanabe, Hideo
    Nakachi, Ichiro
    Satomi, Ryosuke
    Nakayama, Sohei
    Ikemura, Sinnosuke
    Terai, Hideki
    Sato, Takashi
    Morosawa, Maiko
    Asano, Koichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (03) : 717 - 722
  • [38] A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients
    Satoshi Yoda
    Kenzo Soejima
    Hiroyuki Yasuda
    Katsuhiko Naoki
    Ichiro Kawada
    Hideo Watanabe
    Ichiro Nakachi
    Ryosuke Satomi
    Sohei Nakayama
    Sinnosuke Ikemura
    Hideki Terai
    Takashi Sato
    Maiko Morosawa
    Koichiro Asano
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 717 - 722
  • [39] A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer
    Ikemura, Shinnosuke
    Naoki, Katsuhiko
    Yasuda, Hiroyuki
    Kawada, Ichiro
    Yoda, Satoshi
    Terai, Hideki
    Sato, Takashi
    Ishioka, Kota
    Arai, Daisuke
    Ohgino, Keiko
    Kamata, Hirofumi
    Miyata, Jun
    Kabata, Hiroki
    Betsuyaku, Tomoko
    Soejima, Kenzo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (04) : 356 - 361
  • [40] S-1 in combination with epirubicin and oxaliplatin (EOS) in Caucasian patients (pts) with advanced or metastatic gastric cancer (AGC): Results of a phase I study
    Moehler, M.
    Melichar, B.
    Obermannova, R.
    Weinmann, A.
    Scigalla, P.
    Kubala, E.
    Mahlberg, R.
    Heinemann, V.
    Tesarova, M.
    Janda, P.
    Biville, F.
    Mansoor, W.
    ANNALS OF ONCOLOGY, 2015, 26
12345